Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

45.0%

9 terminated/withdrawn out of 20 trials

Success Rate

35.7%

-50.8% vs industry average

Late-Stage Pipeline

20%

4 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

4 recruiting8 terminated

Enrollment Performance

Analytics

Phase 2
11(55.0%)
Phase 1
5(25.0%)
Phase 3
4(20.0%)
20Total
Phase 2(11)
Phase 1(5)
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT07435571Phase 2Not Yet Recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal Osteoarthritis

Role: lead

NCT06678984Phase 3Not Yet Recruiting

Treated Umbilical Vein Allograft (UVT) Versus Autologous Fascial Pubovaginal Sling in the Treatment of Female Stress Urinary Incontinence

Role: lead

NCT06038331Phase 2Recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

Role: lead

NCT06034262Phase 2Recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis

Role: lead

NCT06450470Phase 3Recruiting

Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus

Role: lead

NCT06723782Phase 2Recruiting

Surgical Release of Hand Tendons with Wrapping of the Released Tendon Using an Amniotic Membrane

Role: lead

NCT05302609Phase 2Terminated

Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface

Role: lead

NCT05250583Phase 2Terminated

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis

Role: lead

NCT05250726Phase 2Completed

Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis

Role: lead

NCT05199155Phase 2Terminated

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

Role: lead

NCT05638139Phase 1Completed

Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment with a Gel and Plug of Wharton's Jelly

Role: lead

NCT05207189Phase 2Completed

Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications

Role: lead

NCT05200000Phase 1Completed

Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis

Role: lead

NCT05191628Phase 2Terminated

Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

Role: lead

NCT05236049Phase 1Completed

Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

Role: lead

NCT05247658Phase 3Terminated

Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR

Role: lead

NCT02430558Phase 1Terminated

Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft

Role: lead

NCT05172349Phase 2Withdrawn

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

Role: lead

NCT02736318Phase 1Terminated

OD-PHOENIX in Talus Osteochondral Lesion

Role: lead

NCT00945399Phase 3Terminated

Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions

Role: lead

All 20 trials loaded